ISM
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis (NCT05186753) | Cogent Biosciences, Inc. | 2022-06-27 |
Track ISM automatically
Every clearance here is in the API, with alerts when new ones post.